Cargando…

Hitting the Target but Missing the Point: Recent Progress towards Adenovirus-Based Precision Virotherapies

SIMPLE SUMMARY: If harnessed appropriately, oncolytic viruses offer significant potential as anti-cancer agents. Such virotherapies can be engineered to replicate inside cancerous cells, stimulating the immune system, spreading daughter virions to surrounding cells and producing additional anticance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cunliffe, Tabitha G., Bates, Emily A., Parker, Alan L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696810/ https://www.ncbi.nlm.nih.gov/pubmed/33187160 http://dx.doi.org/10.3390/cancers12113327

Ejemplares similares

Precision virotherapies: Coming soon
por: Uusi-Kerttula, Hanni, et al.
Publicado: (2018)

Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma
por: Panek, Wojciech K., et al.
Publicado: (2017)

Identification of folate receptor α (FRα) binding oligopeptides and their evaluation for targeted virotherapy applications
por: Hulin-Curtis, Sarah L., et al.
Publicado: (2020)

Development of a low-seroprevalence, αvβ6 integrin-selective virotherapy based on human adenovirus type 10
por: Bates, Emily A., et al.
Publicado: (2022)

The Feasibility of Pressurised Intraperitoneal Aerosolised Virotherapy (PIPAV) to Administer Oncolytic Adenoviruses
por: Tate, Sophia J., et al.
Publicado: (2021)

Targeting strategies of adenovirus-mediated gene therapy and virotherapy for prostate cancer
por: Cai, Zhonglin, et al.
Publicado: (2017)

Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer
por: Nguyen, Tien V, et al.
Publicado: (2018)

Progress of oncolytic virotherapy for neuroblastoma
por: Chen, Xiao-Tong, et al.
Publicado: (2022)

Targeting tumor vasculature through oncolytic virotherapy: recent advances
por: Toro Bejarano, Marcela, et al.
Publicado: (2015)

Biodistribution Analysis of Oncolytic Adenoviruses in Canine Patient Necropsy Samples Treated with Cellular Virotherapy
por: Gómez, Ana, et al.
Publicado: (2020)

Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances
por: Simpson, Guy R, et al.
Publicado: (2016)

Oncolytic virotherapy for human malignant mesothelioma: recent advances
por: Boisgerault, Nicolas, et al.
Publicado: (2015)

The Hitchhiker's Guide to Virotherapy
por: Donnelly, Oliver, et al.
Publicado: (2012)

Experimental virotherapy of chemoresistant pancreatic carcinoma using infectivity-enhanced fiber-mosaic oncolytic adenovirus
por: Kaliberov, Sergey A., et al.
Publicado: (2014)

Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
por: Mahasa, Khaphetsi Joseph, et al.
Publicado: (2020)

File loss: hits and near misses
por: Ioannidis Pantopikos, Alexandros, et al.
Publicado: (2018)

Leukaemia stem cells: hit or miss?
por: Glauche, I, et al.
Publicado: (2007)

Africa 2010 in retrospect: hits and misses
por: Davis, Robert
Publicado: (2010)

Oncolytic Sendai virus-based virotherapy for cancer: recent advances
por: Saga, Kotaro, et al.
Publicado: (2015)

Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances
por: Kwan, Amy, et al.
Publicado: (2021)

Oncolytic virotherapy: basic principles, recent advances and future directions
por: Lin, Danni, et al.
Publicado: (2023)

Engineering Cancer Selective Virotherapies: Are the Pieces of the Puzzle Falling into Place?
por: Swift, Emma A., et al.
Publicado: (2022)

Defining a murine ovarian cancer model for the evaluation of conditionally-replicative adenovirus (CRAd) virotherapy agents
por: González-Pastor, Rebeca, et al.
Publicado: (2019)

Virotherapy in Cancer
por: Motalleb, Gholamreza
Publicado: (2013)

ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012)

Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5(NULL)-A20
por: Davies, James A., et al.
Publicado: (2021)

Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm
por: Guan, Mingxu, et al.
Publicado: (2014)

Real-Time Fluorescence Image-Guided Oncolytic Virotherapy for Precise Cancer Treatment
por: Yano, Shuya, et al.
Publicado: (2021)

COVID-19 response in Colombia: Hits and misses
por: Prada, Sergio I., et al.
Publicado: (2022)

Evaluation of polymer shielding for adenovirus serotype 6 (Ad6) for systemic virotherapy against human prostate cancers
por: Nguyen, Tien V, et al.
Publicado: (2016)

Special Issue “Recent Advances in Morbillivirus Vaccine Development and Oncolytic Virotherapy”
por: Lin, Liang-Tzung
Publicado: (2020)

Graphene metasurface hits the point
por: Qin, Jiazheng, et al.
Publicado: (2023)

Virotherapy: cancer gene therapy at last?
por: Bilsland, Alan E., et al.
Publicado: (2016)

Hitting the Target but Missing the Point? Modelling Health and Economic Impacts of Different Approaches to Meeting the Global Action Plan for Physical Activity Target
por: Mizdrak, Anja, et al.
Publicado: (2021)

Personalized virotherapy in cancer
por: Cafferata, Eduardo G, et al.
Publicado: (2015)

Advances in oncolytic virotherapy
por: Russell, Stephen J., et al.
Publicado: (2022)

Editorial: Oncolytic virotherapy
por: Al-Shammari, Ahmed Majeed, et al.
Publicado: (2023)

Surgical Education in the 21st Century: Hit or Miss?
por: McDougall, Elspeth M.
Publicado: (2004)

Hits and misses of Bangladesh National Health Policy 2011
por: Murshid, Munzur-E-, et al.
Publicado: (2020)

Hits and Misses: Digital Contact Tracing in a Pandemic
por: Garry, Maryanne, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rubopb0al65bih83kirk2gs6t5